Headline source record
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
Read the original at Ars Technica
- Publisher’s headline
- FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
- Published by source
- Publication string supplied
- Tue, 10 Nov 2026 14:43:49 +0000
- Updated by source
- Not supplied
- First observed
- Current version captured
- Last observed in feed
- Feed last successfully checked
- Capture scope
- Headline metadata; article body not captured
- Latest feed check
- ok
Observed history
- Observed version 1 ·
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
View metadata snapshot
A source can change between checks. This history begins with our first observation. An absent feed entry or unsuccessful request does not establish removal.